Involvement of P-glycoprotein in the transport of saquinavir and indinavir in rat brain microvessel endothelial and microglia cell lines

Patrick T Ronaldson, Gloria Lee, Shannon Dallas, Reina Bendayan

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Purpose. Membrane-bound efflux transporters, such as P-glycoprotein (P-gp). may limit the brain entry and distribution of HIV-1 protease inhibitors and be in part responsible for HIV-1-associated dementia treatment failure. The purpose of this study was to characterize the transport properties of saquinavir and indinavir in a brain microvessel endothelial cell line and in microglia, the immune cells of the brain and primary HIV-1 cellular target. Methods. Biochemical and transport studies were performed in an immortalized rat brain endothelial cell line (RBE4), a rat microglia cell line (MLS-9). and a P-gp overexpressing Chinese hamster ovary cell line (CHRC5). Results. Western blot analysis using the P-gp monoclonal antibody C219 detected a single band at approximately 170 to 180 kDa (a size previously reported for P-gp) in all cell lines. Cellular accumulation of [14C]saquinavir and [ 3H]indinavir by RBE4, MLS-9, and CHRC5 monolayers was significantly enhanced in the presence of P-gp inhibitors, HIV-1 protease inhibitors, the ATPase inhibitor sodium azide, and the ATP depleting agent 2′,4′-dinitrophenol respectively. [14C]Saquinavir and [3H]indinavir efflux from both cell systems was rapid and significantly reduced in the presence of PSC833. Conclusions. These results provide evidence for P-gp mediated transport of saquinavir and indinavir in RBE4 and MLS-9 and suggest that this transporter can restrict, at least in part, the permeation of HIV-1 protease inhibitors at both the brain barrier site and in brain parenchyma.

Original languageEnglish (US)
Pages (from-to)811-818
Number of pages8
JournalPharmaceutical Research
Volume21
Issue number5
DOIs
StatePublished - May 2004
Externally publishedYes

Fingerprint

Saquinavir
Indinavir
Microglia
P-Glycoprotein
Microvessels
Rats
Brain
Endothelial Cells
Cells
HIV Protease Inhibitors
Cell Line
Protease Inhibitors
Endothelial cells
HIV-1
2,4-Dinitrophenol
Sodium Azide
Cricetulus
Treatment Failure
Permeation
Transport properties

Keywords

  • Central nervous system
  • Drug transport
  • Indinavir
  • P-glycoprotein
  • Saquinavir

ASJC Scopus subject areas

  • Chemistry(all)
  • Pharmaceutical Science
  • Pharmacology

Cite this

Involvement of P-glycoprotein in the transport of saquinavir and indinavir in rat brain microvessel endothelial and microglia cell lines. / Ronaldson, Patrick T; Lee, Gloria; Dallas, Shannon; Bendayan, Reina.

In: Pharmaceutical Research, Vol. 21, No. 5, 05.2004, p. 811-818.

Research output: Contribution to journalArticle

@article{d58bb78b551b4cdc8eadb092f5a42572,
title = "Involvement of P-glycoprotein in the transport of saquinavir and indinavir in rat brain microvessel endothelial and microglia cell lines",
abstract = "Purpose. Membrane-bound efflux transporters, such as P-glycoprotein (P-gp). may limit the brain entry and distribution of HIV-1 protease inhibitors and be in part responsible for HIV-1-associated dementia treatment failure. The purpose of this study was to characterize the transport properties of saquinavir and indinavir in a brain microvessel endothelial cell line and in microglia, the immune cells of the brain and primary HIV-1 cellular target. Methods. Biochemical and transport studies were performed in an immortalized rat brain endothelial cell line (RBE4), a rat microglia cell line (MLS-9). and a P-gp overexpressing Chinese hamster ovary cell line (CHRC5). Results. Western blot analysis using the P-gp monoclonal antibody C219 detected a single band at approximately 170 to 180 kDa (a size previously reported for P-gp) in all cell lines. Cellular accumulation of [14C]saquinavir and [ 3H]indinavir by RBE4, MLS-9, and CHRC5 monolayers was significantly enhanced in the presence of P-gp inhibitors, HIV-1 protease inhibitors, the ATPase inhibitor sodium azide, and the ATP depleting agent 2′,4′-dinitrophenol respectively. [14C]Saquinavir and [3H]indinavir efflux from both cell systems was rapid and significantly reduced in the presence of PSC833. Conclusions. These results provide evidence for P-gp mediated transport of saquinavir and indinavir in RBE4 and MLS-9 and suggest that this transporter can restrict, at least in part, the permeation of HIV-1 protease inhibitors at both the brain barrier site and in brain parenchyma.",
keywords = "Central nervous system, Drug transport, Indinavir, P-glycoprotein, Saquinavir",
author = "Ronaldson, {Patrick T} and Gloria Lee and Shannon Dallas and Reina Bendayan",
year = "2004",
month = "5",
doi = "10.1023/B:PHAM.0000026433.27773.47",
language = "English (US)",
volume = "21",
pages = "811--818",
journal = "Pharmaceutical Research",
issn = "0724-8741",
publisher = "Springer New York",
number = "5",

}

TY - JOUR

T1 - Involvement of P-glycoprotein in the transport of saquinavir and indinavir in rat brain microvessel endothelial and microglia cell lines

AU - Ronaldson, Patrick T

AU - Lee, Gloria

AU - Dallas, Shannon

AU - Bendayan, Reina

PY - 2004/5

Y1 - 2004/5

N2 - Purpose. Membrane-bound efflux transporters, such as P-glycoprotein (P-gp). may limit the brain entry and distribution of HIV-1 protease inhibitors and be in part responsible for HIV-1-associated dementia treatment failure. The purpose of this study was to characterize the transport properties of saquinavir and indinavir in a brain microvessel endothelial cell line and in microglia, the immune cells of the brain and primary HIV-1 cellular target. Methods. Biochemical and transport studies were performed in an immortalized rat brain endothelial cell line (RBE4), a rat microglia cell line (MLS-9). and a P-gp overexpressing Chinese hamster ovary cell line (CHRC5). Results. Western blot analysis using the P-gp monoclonal antibody C219 detected a single band at approximately 170 to 180 kDa (a size previously reported for P-gp) in all cell lines. Cellular accumulation of [14C]saquinavir and [ 3H]indinavir by RBE4, MLS-9, and CHRC5 monolayers was significantly enhanced in the presence of P-gp inhibitors, HIV-1 protease inhibitors, the ATPase inhibitor sodium azide, and the ATP depleting agent 2′,4′-dinitrophenol respectively. [14C]Saquinavir and [3H]indinavir efflux from both cell systems was rapid and significantly reduced in the presence of PSC833. Conclusions. These results provide evidence for P-gp mediated transport of saquinavir and indinavir in RBE4 and MLS-9 and suggest that this transporter can restrict, at least in part, the permeation of HIV-1 protease inhibitors at both the brain barrier site and in brain parenchyma.

AB - Purpose. Membrane-bound efflux transporters, such as P-glycoprotein (P-gp). may limit the brain entry and distribution of HIV-1 protease inhibitors and be in part responsible for HIV-1-associated dementia treatment failure. The purpose of this study was to characterize the transport properties of saquinavir and indinavir in a brain microvessel endothelial cell line and in microglia, the immune cells of the brain and primary HIV-1 cellular target. Methods. Biochemical and transport studies were performed in an immortalized rat brain endothelial cell line (RBE4), a rat microglia cell line (MLS-9). and a P-gp overexpressing Chinese hamster ovary cell line (CHRC5). Results. Western blot analysis using the P-gp monoclonal antibody C219 detected a single band at approximately 170 to 180 kDa (a size previously reported for P-gp) in all cell lines. Cellular accumulation of [14C]saquinavir and [ 3H]indinavir by RBE4, MLS-9, and CHRC5 monolayers was significantly enhanced in the presence of P-gp inhibitors, HIV-1 protease inhibitors, the ATPase inhibitor sodium azide, and the ATP depleting agent 2′,4′-dinitrophenol respectively. [14C]Saquinavir and [3H]indinavir efflux from both cell systems was rapid and significantly reduced in the presence of PSC833. Conclusions. These results provide evidence for P-gp mediated transport of saquinavir and indinavir in RBE4 and MLS-9 and suggest that this transporter can restrict, at least in part, the permeation of HIV-1 protease inhibitors at both the brain barrier site and in brain parenchyma.

KW - Central nervous system

KW - Drug transport

KW - Indinavir

KW - P-glycoprotein

KW - Saquinavir

UR - http://www.scopus.com/inward/record.url?scp=2442673340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442673340&partnerID=8YFLogxK

U2 - 10.1023/B:PHAM.0000026433.27773.47

DO - 10.1023/B:PHAM.0000026433.27773.47

M3 - Article

C2 - 15180339

AN - SCOPUS:2442673340

VL - 21

SP - 811

EP - 818

JO - Pharmaceutical Research

JF - Pharmaceutical Research

SN - 0724-8741

IS - 5

ER -